Overall Status

Completed (10)

Recruiting (5)

Active, not recruiting (3)

Not yet recruiting (2)

Terminated (2)

Withdrawn (2)

No longer available (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (6)

phase 1 (4)

phase 1/phase 2 (4)

phase 4 (2)

early phase 1 (1)

phase 3 (1)

Collaborator

Celgene (1)

Hoffmann-La Roche (1)

Leiden University Medical Center (1)

Mallinckrodt (1)

Micreos (1)

Millennium Pharmaceuticals, Inc. (1)

Purdue University (1)

Study Documents

Intervention Type

drug (18)

other (3)

biological (2)

device (1)

diagnostic test (1)

radiation (1)

Funder Type

Industry (12)

Other (12)

NIH (1)

U.S. Fed (1)

Study Type

Interventional (18)

Observational (6)

Expanded Access (1)

Observational [Patient Registry] (1)

Lymphoma, T-Cell, Cutaneous

Showing 26 - 26 of 26

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Leukemia, T-Cell, Lymphoma, T-Cell, Cutaneous Trial run by the NCI (Yttrium-90 radiolabeled anti-Tac antibody)

Completed

Leukemia, T-Cell
Lymphoma, T-Cell, Cutaneous

Yttrium-90 radiolabeled anti-Tac antibody

Bethesda, Maryland

National Cancer Institute (NCI)

Mar 3, 2008